Abstracts were Metastatic Genitourinary Malignancies | Mix of Urothelial Carcinoma, Prostate Cancer, & RCC
Nataliya Mar, MD, UC Irvine Health, shares her Abstracts were Metastatic Genitourinary Malignancies | Mix of Urothelial Carcinoma, Prostate Cancer, & RCC at MOASC 2018 Author: moasc Added: 08/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 14, 2018 Category: Cancer & Oncology Source Type: podcasts

PROSPECT: how effective is the new prostvac vaccine against prostate cancer?
In this video, James Gulley, MD, PhD, FACP, of the National Cancer Institute, Bethesda, MD, speaks about prostvac, a novel vaccine his research group is developing to combat prostate cancer. Dr Gulley... Author: VJOncology Added: 08/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2018 Category: Cancer & Oncology Source Type: podcasts

Prostate cancer updates from ASCO 2018
Promising genitourinary cancer updates were presented at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL. Neal Shore, MD, of Carolina Urologic Research Center, Myrtle ... Author: VJOncology Added: 08/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 3, 2018 Category: Cancer & Oncology Source Type: podcasts

Evaluation of a DNA vaccine for prostate cancer
Cancer vaccines are a promising immunotherapeutic area, particularly in the field of prostate cancer. Here, Neal Shore, MD, of Carolina Urologic Research Center, Myrtle Beach, SC, discusses a clinical... Author: VJOncology Added: 07/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 31, 2018 Category: Cancer & Oncology Source Type: podcasts

The future of prostate cancer therapy
Prostate cancer therapy has seen radical changes and improvements recently, with a multitude of clinical trials currently underway. Speaking from the American Society of Oncology (ASCO) 2018 Annual Me... Author: VJOncology Added: 07/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 31, 2018 Category: Cancer & Oncology Source Type: podcasts

LATITUDE: combination therapy for newly diagnosed prostate cancer
In this interview, Karim Fizazi, MD, PhD, of the University of Paris-Sud, Orsay, France gives an overview of the LATITUDE study (NCT01715285), which investigated whether patients with newly diagnosed ... Author: VJOncology Added: 07/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 27, 2018 Category: Cancer & Oncology Source Type: podcasts

Imaging as an effective solution for prostate cancer diagnosis
Nicholas J. Vogelzang, MD, shares his thoughts on imaging as an effective solution for prostate cancer diagnosis at ASCO 2018. Author: obr Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts

Vogelzang Question 3
Nicholas J. Vogelzang, MD, shares his thoughts on imaging as an effective solution for prostate cancer diagnosis at ASCO 2018. Author: obr Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts

How MRI has improved diagnosing in prostate cancer
Nicholas J. Vogelzang, MD, talks about how MRI has improved the diagnosis of prostate cancer at ASCO 2018. Author: obr Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts

Avoiding under-diagnosing & over-diagnosing prostate cancer
Nicholas J. Vogelzang, MD, explains explains how to avoid under-diagnosing & over-diagnosing prostate cancer at ASCO 2018. Author: obr Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts

The PROSPER and SPARTAN studies are impacting standard of care
Tomasz M. Beer, MD, talks about how the the PROSPER (enzalutamide) and SPARTAN (apalutamide) studies in non-metastatic castrate-resistant prostate cancer are impacting standard of care at ASCO 2018. Author: obr Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Latest trends in the multimodality treatment of prostate cancer
Tomasz M. Beer, MD, discusses the latest trends in the multimodality treatment of prostate cancer at ASCO 2018. Author: obr Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

How to avoid under-diagnosing and over-diagnosing prostate cancer
Tomasz M. Beer, MD, explains how to avoid under diagnosing and over diagnosing prostate cancer at ASCO 2018. Author: obr Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Central themes regarding prostate cancer at ASCO 2018
Tomasz M. Beer, MD, explains the central themes regarding prostate cancer here at ASCO 2018. Author: obr Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Role of immunotherapy in prostate cancer
Celestia S. Higano, MD, shares her thoughts on how immunotherapy is currently being integrated into castrate resistant prostate cancer treatment algorithms at ASCO 2018. Author: obr Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts